Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MGAT1 Polyclonal Antibody
Goat Polyclonal Antibody
Supplier: Invitrogen™ PA519371
Description
This antibody is predicted to react with bovine, canine, mouse and rat based on sequence homology. This antibody is tested in Peptide ELISA: antibody detection limit dilution 8,000.
There are believed to be over 100 different glycosyltransferases involved in the synthesis of protein-bound and lipid-bound oligosaccharides. UDP-N-acetylglucosamine:alpha-3-D-mannoside beta-1, 2-N-acetylglucosaminyltransferase I is a medial-Golgi enzyme essential for the synthesis of hybrid and complex N-glycans. The protein, encoded by a single exon, shows typical features of a type II transmembrane protein. The protein is believed to be essential for normal embryogenesis. Several variants encoding the same protein have been found for this gene.
Specifications
MGAT1 | |
Polyclonal | |
Unconjugated | |
MGAT1 | |
alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase; GGNT1; glcNAc-T I; GLCNAC-TI; GLCT1; GLYT1; Gnt1; GNT-1; GnTI; GNT-I; mannoside acetylglucosaminyltransferase 1; mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase; MGAT; Mgat1; Mgat-1; MGAT1 gene for N-acetylglucosaminyltransferase; N-acetylglucosaminyltransferase I; N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I; OTTHUMP00000161546 | |
Goat | |
Ammonium Sulfate Precipitation | |
RUO | |
4245 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
0.5 mg/mL | |
TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
P26572 | |
MGAT1 | |
Synthetic peptide sequence (QVEKVRTNDR) corresponding to the internal amino acids of MGAT1 (aa 369-379). | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction